Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
gamma-Aminobutyric Acid
Pregnancy-Associated alpha 2-Macroglobulins
Combination therapy with statins: who benefits?
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination therapy with statins: who benefits?
Combination therapy with statins: who benefits? Endocrinol Metab Clin North Am. 2014 Dec; 43(4):993-1006.
View in:
PubMed
subject areas
Cardiovascular Diseases
Drug Therapy, Combination
Fenofibrate
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Niacin
authors with profiles
Michael Davidson